Brain Injury clinical trials at UC Cancer
1 research study open to eligible people
open to eligible people ages 18-65
This study will assess the combined effectiveness of repetitive transcranial magnetic stimulation (rTMS) and telehealth based therapy in helping manage mild traumatic brain injury (mTBI) related headaches. The investigators hypothesize that active rTMS combined with telehealth therapy will provide marked reduction in mTBI related headaches and symptoms in comparison to their placebo counterparts.
Our lead scientists for Brain Injury research studies include Albert Y Leung, MD.